MaxCyte

Rockville, MD

CEO: Doug Doerfler

http://www.maxcyte.com

MaxCyte provides clinical/commercial cell modification technologies and expertise to the global leaders in life sciences. The company’s transfection technology platform enables the discovery, development, manufacturing and delivery of innovative and important therapeutic products for a wide range of diseases.